Remeron Related Published Studies
Well-designed clinical trials related to Remeron (Mirtazapine)
Mirtazapine to reduce methamphetamine use: a randomized controlled trial. [2011.11]
Adjunct mirtazapine for negative symptoms of schizophrenia. [2011.10]
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. [2011.07.30]
More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia. [2011.06.01]
Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype. [2011.05]
Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase. [2011.04.06]
Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. [2011.04]
Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial. [2011.01.15]
Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF-R1 increase: data from the MIND-IT. [2011]
Adjunct mirtazapine for negative symptoms of schizophrenia. [2011]
Mirtazapine augmentation enhances cognitive and reduces negative symptoms in
schizophrenia patients treated with risperidone: a randomized controlled trial. [2011]
Efficacy of mirtazapine in preventing intrathecal morphine-induced nausea and vomiting after orthopaedic surgery*. [2010.12]
A single dose of mirtazapine modulates neural responses to emotional faces in healthy people. [2010.12]
Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. [2010.09.21]
More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial. [2010.08]
Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment. [2010.06]
Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial. [2010.05.15]
Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study. [2010.05]
Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder. [2010.02]
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial. [2010.02]
More evidence on additive antipsychotic effect of adjunctive mirtazapine in
schizophrenia: an extension phase of a randomized controlled trial. [2010]
Mirtazapine in generalized social anxiety disorder: a randomized, double-blind,
placebo-controlled study. [2010]
Remission with mirtazapine and selective serotonin reuptake inhibitors: a
meta-analysis of individual patient data from 15 controlled trials of acute phase
treatment of major depression. [2010]
The effect of mirtazapine add on therapy to risperidone in the treatment of
schizophrenia: a double-blind randomized placebo-controlled trial. [2010]
Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind,
randomized, placebo-controlled study. [2010]
Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation. [2009.07]
Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers. [2009.06]
Early effects of mirtazapine on emotional processing. [2009.05]
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial. [2009.04]
Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients. [2009.03]
Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: a double-blind, randomized, placebo-controlled trial. [2009.03]
Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: A double-blind, randomized, placebo-controlled trial. [2009.01.12]
The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients. [2008.12]
Neuroimaging of mirtazapine enantiomers in humans. [2008.10]
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. [2008.09]
Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. [2008.06.01]
A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. [2008.05]
Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression. [2008.04]
Mirtazapine decreases the pain feeling in healthy participants. [2008.02]
Venlafaxine versus Mirtazapine in the Treatment of Undifferentiated Somatoform Disorder : A 12-Week Prospective, Open-Label, Randomized, Parallel-Group Trial. [2008]
Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. [2007.09]
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. [2007.04.05]
Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache. [2007.02]
Efficacy of mirtazapine in obstructive sleep apnea syndrome. [2007.01.01]
Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study. [2007.01]
Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study. [2007]
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. [2006.12.27]
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. [2006.09]
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. [2006.07]
Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients. [2006.07]
Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial. [2006.06.01]
Cerebrovascular reactivity following administration of mirtazapine in healthy probands--a randomized, placebo controlled double-blind clinical study. [2006.06]
Mirtazapine Orally Disintegrating Tablets Versus Venlafaxine Extended Release: A Double-blind, Randomized Multicenter Trial Comparing the Onset of Antidepressant Response in Patients With Major Depressive Disorder. [2006.02]
Mirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled study. [2005.12]
Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study. [2005.09]
Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation. [2005.04]
Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial. [2005.04]
Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial. [2005.04]
Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification. [2005.01]
Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients. [2005]
Well-designed clinical trials possibly related to Remeron (Mirtazapine)
Pharmacotherapy to control behavioral symptoms in children with autism. [2012]
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. [2011.10]
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. [2011.07]
Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial. [2011.07]
Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol. [2011.05.11]
If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. [2011.01.01]
Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled
randomized trials. [2011]
Modafinil reduces microsleep during partial sleep deprivation in depressed patients. [2010.10]
Guideline recommendations for long-term treatment of depression with antidepressants in primary care--a critical review. [2010.06]
FKBP5 polymorphisms and antidepressant response in geriatric depression. [2010.03.05]
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. [2010.03]
Guideline recommendations for long-term treatment of depression with
antidepressants in primary care--a critical review. [2010]
Modafinil reduces microsleep during partial sleep deprivation in depressed
patients. [2010]
FKBP5 polymorphisms and antidepressant response in geriatric depression. [2010]
Assessment of the test-retest reliability of laboratory polysomnography. [2009.05]
Is the antidepressant venlafaxine effective for the treatment of functional dyspepsia? [2009.02]
Impact of the WHO depression guideline on patient care by psychiatrists: a randomized controlled trial. [2008.09]
The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. [2008.03]
Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression. [2008.02]
Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis. [2007.12]
The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. [2007.11.20]
A monoamine oxidase B gene variant and short-term antidepressant treatment response. [2007.10.01]
Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. [2007.09]
The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions. [2007.08]
A monoamine oxidase B gene variant and short-term antidepressant treatment response. [2007.06.07]
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. [2007.04.18]
Verbal memory performance during subchronic challenge with a selective serotonergic and a mixed action antidepressant. [2006.10]
Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study. [2006.03]
Serotonergic modulation of neuronal responses to behavioural inhibition and reinforcing stimuli: an fMRI study in healthy volunteers. [2006.01]
Centrally active nonhormonal hot flash therapies. [2005.12.19]
Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. [2005.09.20]
Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed? [2005.09]
Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study. [2005]
Other research related to Remeron (Mirtazapine)
The effects of mirtazapine on sleep in patients with major depressive disorder. [2012]
The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid
depression. [2012]
Psychiatric Co-morbidity and Efficacy of Mirtazapine Treatment in Young Subjects With Chronic or Cyclic Vomiting Syndromes: A Case Series. [2011.07]
Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder. [2011.07]
The acute effects of mirtazapine on pain related behavior in healthy animals. [2011.07]
Review of the use of mirtazapine in the treatment of depression. [2011.07]
Mirtazapine versus other antidepressive agents for depression. [2011]
More evidence on proneurocognitive effects of add-on mirtazapine in
schizophrenia. [2011]
|
